SPL13B Antibody

What is SPL13B and why is it significant in plant biology research?

SPL13B (SQUAMOSA promoter binding protein-like 13B) is a transcription factor in Arabidopsis thaliana that belongs to the SPL family of plant-specific transcription factors. These proteins play crucial roles in plant development, including flowering time regulation, leaf development, and vegetative phase change. SPL13B is particularly significant because it contains the highly conserved SBP (SQUAMOSA promoter binding protein) domain that binds to DNA and regulates downstream gene expression. Research with SPL13B antibodies allows scientists to study protein expression patterns, protein-protein interactions, and transcriptional regulatory networks in plant developmental biology .

What are the key specifications of commercially available SPL13B antibodies?

The commercially available polyclonal SPL13B antibody (e.g., CSB-PA319129XA01DOA) is generated in rabbits using recombinant Arabidopsis thaliana SPL13B protein as the immunogen. The antibody is supplied in liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. It has undergone antigen affinity purification and demonstrates reactivity specifically with Arabidopsis thaliana. As a polyclonal IgG antibody, it has been validated for applications including ELISA and Western blotting. Researchers should note the lead time for acquisition is typically 14-16 weeks as it is manufactured on a made-to-order basis .

How does the clonality of SPL13B antibody affect experimental design and interpretation?

The SPL13B antibody described in the specifications is polyclonal, which has important implications for experimental design and data interpretation. Unlike monoclonal antibodies that recognize a single epitope, polyclonal antibodies bind to multiple epitopes on the target antigen, providing these methodological considerations:

Experimental Design Implications:

For critical experiments requiring absolute specificity or those aiming to distinguish between closely related SPL family members, researchers should conduct thorough validation including peptide competition assays and knockout/knockdown controls to confirm antibody specificity .

What are the validated applications for SPL13B antibodies and their optimization parameters?

The SPL13B antibody has been validated for ELISA and Western blotting (WB) applications . Based on general antibody methodology principles, researchers should consider these application-specific parameters:

Western Blotting:

• Recommended dilution range: Start with 1:1000-1:2000 and optimize

• Blocking: 5% non-fat milk or BSA in TBST

• Sample preparation: Include both denatured and non-denatured lysates initially to determine optimal conditions

• Controls: Include positive control (Arabidopsis thaliana extracts) and negative control (non-plant or knockout samples)

• Detection: Secondary anti-rabbit IgG with appropriate conjugate

ELISA:

• Recommended dilution range: Start with 1:5000-1:10000 and optimize

• Coating concentration: 1-10 μg/ml of target antigen

• Blocking: 1-3% BSA in PBS

• Detection: HRP or AP-conjugated secondary antibody with appropriate substrate

For both applications, researchers should perform systematic titration experiments to determine optimal antibody concentration for their specific experimental conditions .

How should researchers properly store and handle SPL13B antibody to maintain functionality?

Proper storage and handling of SPL13B antibody is critical for maintaining its functionality and ensuring experimental reproducibility. The manufacturer recommends storage at -20°C or -80°C upon receipt, avoiding repeated freeze-thaw cycles . Based on general antibody principles, researchers should follow these methodological guidelines:

• Aliquoting: Upon receipt, divide the antibody into small single-use aliquots (typically 10-20 μl) in sterile microcentrifuge tubes to minimize freeze-thaw cycles

• Storage conditions: Store aliquots at -20°C for short-term (up to 1 year) or -80°C for long-term storage

• Thawing protocol: Thaw aliquots on ice, never at room temperature

• Working dilutions: Prepare fresh working dilutions on the day of experiment; do not store diluted antibody solutions for extended periods

• Transport: When removing from freezer, transport on ice and return to freezer promptly

• Temperature monitoring: Ensure freezer temperatures are regularly monitored and maintain an uninterrupted cold chain

Additionally, researchers should document the number of freeze-thaw cycles and storage duration in their experimental records, as these factors can affect antibody performance and contribute to experimental variability .

What is the recommended protocol for validating SPL13B antibody specificity in plant research?

Validation of antibody specificity is a critical step before conducting substantial experiments with SPL13B antibody. A comprehensive validation protocol should include:

• Positive and negative controls:

  • Positive: Wild-type Arabidopsis thaliana expressing SPL13B

  • Negative: Non-plant tissue or SPL13B knockout/knockdown lines

• Peptide competition/blocking assay:

  • Pre-incubate the antibody with excess purified SPL13B protein or immunizing peptide

  • Run parallel Western blots with blocked and unblocked antibody

  • Specific bands should be diminished or absent in the blocked sample

• Molecular weight verification:

  • Confirm that the detected protein band matches the predicted molecular weight of SPL13B

  • Account for potential post-translational modifications

• Cross-reactivity assessment:

  • Test against closely related SPL family members

  • Test in other plant species if cross-species reactivity is claimed

• Method comparison:

  • Compare results with other detection methods (e.g., mRNA expression, tagged protein detection)

• Lot-to-lot verification:

  • For critical research, verify new antibody lots against previous lots

This systematic validation approach helps ensure experimental results are truly reflective of SPL13B biology rather than artifacts of non-specific antibody binding .

How can SPL13B antibody be utilized in chromatin immunoprecipitation (ChIP) studies?

While the SPL13B antibody specifications do not explicitly list ChIP as a validated application , researchers interested in adapting it for ChIP to study DNA-binding properties of SPL13B should consider this methodological approach:

• Preliminary validation:

  • Confirm antibody specificity by Western blot using nuclear extracts

  • Verify ability to immunoprecipitate native SPL13B protein

• ChIP protocol optimization:

  • Crosslinking conditions: Test different formaldehyde concentrations (0.5-1.5%) and incubation times (5-20 minutes)

  • Sonication parameters: Optimize to achieve chromatin fragments of 200-500 bp

  • Antibody amount: Typically start with 2-5 μg per reaction and titrate

  • Wash stringency: Balance between reducing background and maintaining specific interactions

• Controls for ChIP experiments:

  • Input chromatin control (pre-immunoprecipitation)

  • IgG control (non-specific antibody of same isotype)

  • Negative genomic regions (not expected to be bound by SPL13B)

  • Positive control regions (known SPL13B binding sites)

• Data analysis considerations:

  • Normalize to input chromatin

  • Compare enrichment to IgG control

  • Calculate statistical significance across biological replicates

Since this polyclonal antibody recognizes multiple epitopes, it may provide robust signal in ChIP applications, though researchers should be aware that batch-to-batch variation could affect reproducibility across long-term studies .

What methodological approaches should be considered when using SPL13B antibody in co-immunoprecipitation (Co-IP) studies?

For researchers interested in using SPL13B antibody for co-immunoprecipitation studies to identify protein-protein interactions, the following methodological considerations are important:

• Buffer optimization:

  • Lysis buffer composition: Test different detergents (NP-40, Triton X-100) at varying concentrations (0.1-1%)

  • Salt concentration: Typically 100-150 mM NaCl for initial attempts, adjust based on results

  • pH conditions: Standard range 7.2-7.6

• Experimental protocol refinements:

  • Pre-clearing: Include a pre-clearing step with protein A/G beads to reduce non-specific binding

  • Antibody-to-protein ratio: Start with 2-5 μg antibody per 500 μg total protein

  • Incubation time and temperature: 2-4 hours at 4°C or overnight

  • Wash stringency: Balance between maintaining specific interactions and reducing background

• Controls:

  • Input control (pre-immunoprecipitation lysate)

  • IgG control (non-specific rabbit IgG)

  • Reverse Co-IP if antibodies to potential interacting partners are available

• Detection methods:

  • Western blotting for known or suspected interacting partners

  • Mass spectrometry for unbiased discovery of interaction partners

• Validation of interactions:

  • Reciprocal Co-IP

  • In vitro binding assays

  • Functional studies (co-localization, mutational analysis)

This experimental framework enables researchers to reliably identify proteins that interact with SPL13B in various physiological or developmental contexts .

What are the considerations for quantitative analysis of SPL13B expression across different plant tissues and developmental stages?

Quantitative analysis of SPL13B expression using the antibody requires careful experimental design and methodological rigor:

• Sample preparation standardization:

  • Harvest tissues at consistent times of day to account for potential circadian regulation

  • Use identical extraction protocols across all samples

  • Normalize protein loading by total protein quantification methods (e.g., BCA assay)

• Quantitative Western blot approach:

  • Include internal loading control (constitutively expressed protein)

  • Create standard curves with recombinant SPL13B protein

  • Use digital imaging systems with linear dynamic range

  • Perform at least three biological replicates

• Tissue-specific analysis considerations:

  • Account for tissue-specific interfering compounds

  • Adapt extraction buffers for different tissue types (leaves, roots, reproductive tissues)

  • Consider subcellular fractionation to assess nuclear vs. cytoplasmic localization

• Developmental time-course design:

  • Define clear developmental stages using standardized criteria

  • Maintain consistent growth conditions

  • Use statistical approaches appropriate for time-series data

• Data normalization and analysis:

  • Normalize SPL13B signal to loading control

  • Apply appropriate statistical tests for comparisons across tissues/stages

  • Consider multivariate analysis for complex developmental patterns

This methodological framework enables researchers to generate reliable quantitative data on SPL13B expression patterns that can be correlated with developmental events or environmental responses .

What are common issues encountered when using SPL13B antibody in Western blotting and their solutions?

Researchers working with SPL13B antibody may encounter several technical challenges in Western blotting. This troubleshooting guide addresses common issues and their methodological solutions:

When optimizing Western blot protocols, researchers should change only one variable at a time and maintain detailed records of all protocol modifications to facilitate reproducibility .

How should researchers address experimental variability when using SPL13B antibody in immunological assays?

Addressing experimental variability is critical for generating reproducible and reliable data with SPL13B antibody. Researchers should implement these methodological strategies:

• Standardization of reagents:

  • Use the same lot of antibody when possible for long-term studies

  • Document lot numbers and prepare large batches of buffers

  • Include standard positive controls in each experiment

• Technical considerations:

  • Maintain consistent incubation times and temperatures

  • Use calibrated pipettes and verify equipment performance

  • Standardize protein quantification methods

• Experimental design approaches:

  • Include technical replicates (minimum of three)

  • Perform multiple biological replicates

  • Randomize sample processing order

  • Include blinding procedures where appropriate

• Data analysis strategies:

  • Use appropriate statistical tests for variability assessment

  • Calculate coefficients of variation between replicates

  • Establish acceptable limits for experimental variability

  • Consider normalization methods appropriate to the specific assay

• Documentation practices:

  • Maintain detailed laboratory notebooks with all protocol parameters

  • Document any deviations from standard protocols

  • Record environmental conditions that might affect experiments

By implementing these strategies, researchers can minimize experimental variability and generate more reliable data when working with SPL13B antibody, particularly important given its polyclonal nature which may introduce inherent variability .

What methodological adaptations are necessary when working with SPL13B antibody in different plant species?

While the SPL13B antibody is specifically raised against Arabidopsis thaliana SPL13B protein , researchers interested in studying related proteins in other plant species should consider these methodological adaptations:

• Cross-reactivity prediction and validation:

  • Perform sequence alignment of SPL13B across species of interest

  • Focus on conservation within the immunogen region used to generate the antibody

  • Validate cross-reactivity empirically through Western blotting with positive controls

• Species-specific protocol adjustments:

  • Extraction buffer optimization: Adjust for species-specific interfering compounds

  • Loading amount: May require higher protein amounts for species with lower homology

  • Blocking conditions: Test different blocking agents (BSA, milk, commercial blockers)

  • Incubation time: May need to increase for lower affinity cross-species detection

• Confirmation strategies:

  • Peptide competition assay using both Arabidopsis and target species peptides

  • Parallel analysis with species-specific molecular techniques (RT-PCR, RNA-seq)

  • If possible, validation in knockout/knockdown lines of the target species

• Data interpretation considerations:

  • Exercise caution when making quantitative comparisons across species

  • Consider differences in protein size and post-translational modifications

  • Account for potential differences in epitope accessibility

• Alternative approaches:

  • For critical cross-species studies, consider generating species-specific antibodies

  • Consider epitope-tagging approaches in non-Arabidopsis systems

These methodological adaptations allow researchers to extend the utility of SPL13B antibodies beyond their primary target species while maintaining scientific rigor and appropriate interpretative caution .

How can epitope mapping enhance the utility of SPL13B antibody in mechanistic studies?

Epitope mapping of the SPL13B antibody can significantly enhance its utility in mechanistic studies by providing precise information about where the antibody binds to the protein. This knowledge informs experimental design and interpretation:

• Methodological approaches to epitope mapping:

  • Peptide array analysis: Testing antibody binding to overlapping peptides spanning SPL13B

  • Deletion mutant analysis: Creating truncated versions of SPL13B to localize binding regions

  • Site-directed mutagenesis: Changing specific amino acids to identify critical binding residues

  • Hydrogen-deuterium exchange mass spectrometry: For conformational epitope identification

• Applications of epitope mapping results:

  • Functional domain interference assessment: Determining if antibody binding interferes with DNA binding or protein-protein interactions

  • Accessibility analysis: Understanding which regions of SPL13B are surface-exposed

  • Cross-reactivity prediction: Better predicting potential cross-reactivity with related SPL proteins

  • Epitope conservation analysis: Evaluating epitope conservation across species for cross-species applications

• Experimental design refinements:

  • Selecting appropriate tags for fusion proteins that won't interfere with antibody binding

  • Designing competition assays with specific peptides

  • Interpreting functional blocking experiments

Knowledge of the specific epitope(s) recognized by the polyclonal SPL13B antibody allows researchers to make more informed decisions about experimental applications and more accurately interpret results, particularly in functional studies where antibody binding might affect protein activity .

What considerations should researchers address when designing multiplex immunoassays that include SPL13B antibody?

Designing multiplex immunoassays that include SPL13B antibody alongside other antibodies requires careful consideration of several methodological factors:

• Antibody compatibility assessment:

  • Species origin compatibility: Avoid using multiple primary antibodies from the same species unless directly labeled

  • Isotype differences: Utilize different isotypes when possible for selective secondary detection

  • Cross-reactivity testing: Perform single-plex controls before multiplexing

• Technical optimization strategies:

  • Sequential immunostaining: Consider sequential rather than simultaneous application for problematic combinations

  • Blocking optimization: Modify blocking protocols to minimize background across all antibodies

  • Signal separation: Ensure sufficient separation of fluorescent signals if using fluorescent detection

• Controls for multiplex assays:

  • Single-antibody controls: Run parallel assays with each antibody individually

  • Secondary-only controls: Verify no cross-reactivity of secondary antibodies

  • Absorption controls: Pre-absorb antibodies with their respective antigens to confirm specificity

• Data acquisition and analysis considerations:

  • Signal normalization: Account for differences in antibody affinity and target abundance

  • Bleed-through correction: Apply appropriate compensation when using multiple fluorophores

  • Quantitative analysis: Develop algorithms that address multiplex-specific variables

• Validation approaches:

  • Orthogonal methods: Confirm key findings with independent techniques

  • Biological controls: Include samples with known expression patterns of target proteins

These methodological considerations help researchers develop robust multiplex assays that can simultaneously detect SPL13B alongside other proteins of interest, enhancing experimental efficiency and providing valuable co-localization or co-expression data .

How should researchers integrate SPL13B antibody data with transcriptomic and other -omics datasets?

Integrating SPL13B antibody-derived protein expression data with transcriptomic and other -omics datasets requires careful methodological consideration to account for the different data types and their inherent limitations:

• Experimental design for integrative studies:

  • Sample coordination: Collect protein and RNA samples from the same biological specimens when possible

  • Temporal alignment: Account for time delays between transcription and translation

  • Biological replication: Ensure sufficient replication for statistical power in integrated analyses

• Data normalization and transformation approaches:

  • Platform-specific normalization: Apply appropriate normalization methods for each data type

  • Scale standardization: Transform data to comparable scales for integration

  • Batch effect correction: Address technical variation between experiments

• Integration analytical methods:

  • Correlation analysis: Calculate correlation coefficients between protein and mRNA levels

  • Principal component analysis: Identify major patterns of variation across data types

  • Network analysis: Construct integrated networks incorporating multiple data types

  • Pathway enrichment: Perform enrichment analysis using integrated datasets

• Validation strategies:

  • Independent cohort validation: Confirm key findings in independent samples

  • Functional validation: Experimentally test predictions from integrated analyses

• Interpretation frameworks:

  • Discordance analysis: Investigate cases where protein and mRNA levels diverge

  • Regulatory mechanism inference: Use integration to identify potential post-transcriptional regulation

  • Temporal dynamics: Consider time-course data to understand expression dynamics

This integrated approach allows researchers to develop more comprehensive models of SPL13B function in plant development by connecting protein-level observations with broader molecular networks and regulatory mechanisms .

What emerging technologies might enhance SPL13B antibody applications in plant research?

Several emerging technologies hold promise for expanding and enhancing SPL13B antibody applications in plant research:

• Advanced microscopy techniques:

  • Super-resolution microscopy: Nanoscale visualization of SPL13B localization

  • Live-cell imaging: Tracking SPL13B dynamics in real-time using antibody fragments

  • Correlative light and electron microscopy (CLEM): Combining subcellular localization with ultrastructural context

• Single-cell applications:

  • Single-cell Western blotting: Quantifying SPL13B in individual cells

  • Mass cytometry (CyTOF): Multiplexed protein detection at single-cell resolution

  • Spatial transcriptomics integration: Correlating protein localization with gene expression

• Proximity labeling approaches:

  • Antibody-directed proximity labeling: Using SPL13B antibody to direct enzymes that label proximal proteins

  • APEX2 or BioID fusion proteins: Complementary approaches to validate antibody-based interaction studies

• Computational advances:

  • Machine learning for antibody specificity prediction: Better predicting cross-reactivity

  • Structural modeling integration: Predicting functional consequences of antibody binding

• Antibody engineering opportunities:

  • Recombinant antibody fragments: Developing smaller versions with improved tissue penetration

  • Plant-expressed antibodies: Production of antibodies within plant systems for in vivo studies

By adopting these emerging technologies, researchers can address current limitations and expand the utility of SPL13B antibodies in plant developmental biology research, potentially revealing new insights into transcription factor dynamics and regulatory networks .

What are best practices for reporting SPL13B antibody usage in scientific publications?

Comprehensive reporting of SPL13B antibody usage in scientific publications is essential for research transparency and reproducibility. Researchers should adhere to these best practices:

• Antibody identification and sourcing:

  • Complete catalog information: Manufacturer, catalog number, lot number

  • RRID (Research Resource Identifier): Include when available

  • Clone name for monoclonal antibodies or immunogen details for polyclonals

  • Species and isotype information

• Validation documentation:

  • Specificity validation: Describe methods used to confirm specificity

  • Reference previous validation studies when applicable

  • Include key validation data as supplementary material

  • Address known limitations or cross-reactivities

• Experimental methods reporting:

  • Complete protocol details: Dilutions, incubation times, temperatures

  • Buffer compositions: Complete formulations of all buffers used

  • Detection systems: Secondary antibodies, visualization methods

  • Image acquisition parameters: Exposure times, gain settings

• Quantification and analysis transparency:

  • Raw data availability: Provide access to unprocessed images/data

  • Analysis methods: Detail software, algorithms, and parameters

  • Statistical approaches: Specify tests, sample sizes, replicate structure

  • Normalization methods: Explain how data was normalized

Adhering to these reporting standards ensures that SPL13B antibody-based research can be properly evaluated and potentially reproduced by other researchers, enhancing scientific rigor and accelerating progress in understanding SPL13B function in plant biology .